Healthcare Malaysian Community
Our community narratives are driven by numbers and valuation.
Healthcare Malaysian Investing Ideas
Alpha IVF: Has the market become too focused on short-term expansion costs and missed the longer-term value?
Alpha IVF Group Berhad is starting to look like one of those healthcare counters where the market may be undervaluing the business in P/E terms by focusing too much on near-term margin pressure and not enough on its medium-term earnings power. At current valuation levels, the stock does not appear excessively demanding for a company that is still profitable, generates strong returns, and is expanding its footprint across Southeast Asia.Read more
Sunway Healthcare’s valuation spike may shine light on smaller healthcare names like PMCK
Sunway Healthcare’s listing has clearly reset the market’s valuation benchmark for private healthcare counters in Malaysia. At IPO, Sunway Healthcare was already being priced at around RM16.7 billion market capitalisation , equivalent to about 64.8 times FY2024 earnings , and after its strong debut its market value reportedly rose further to around RM21.3 billion.Read more
Technical Analysis: Alpha IVF Group Berhad (KLSE: ALPHA)
Price Structure & Momentum. Alpha IVF is currently pivoting from a consolidation phase into a high-potential recovery setup, trading at RM 0.295.Read more
IHH: Dividend Payments And Profit Margins Will Influence Healthcare Sector Outlook
Key Takeaways Expansion of day care services and operational efficiency programs are structurally improving margins, return on equity, and cost savings across key markets. Growth in foreign patient volumes and investments in digital and premium care initiatives are driving higher patient revenue and supporting sustained top-line and EBITDA growth.Read more
